RXRX vs VTRS · rev $14.1M vs rev $7.27B
Recursion Pharmaceuticals Inc (RXRX) versus Viatris Inc (VTRS) — a side-by-side from cached financials, not a winner call.
Recursion Pharmaceuticals Inc (RXRX) is a biotechnology company listed on NASDAQ.
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported RXRX revenue for 2026-06-30 was $14.1M. Net income was -$248.5M. RXRX currently screens at market cap $1.75B.
Latest reported VTRS revenue for 2026-06-30 was $7.27B. VTRS currently screens at market cap $10.83B.
RXRX currently screens at market cap $1.75B. VTRS currently screens at market cap $10.83B.
Not investment advice. Open the RXRX and VTRS stock pages for the full models.
Not investment advice.